BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

693 related articles for article (PubMed ID: 22019647)

  • 1. Does the chronic inflammatory demyelinating polyradiculoneuropathy due to secondary cause differ from primary?
    Wadwekar V; Kalita J; Misra UK
    Neurol India; 2011; 59(5):664-8. PubMed ID: 22019647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of clinically atypical with typical chronic inflammatory demyelinating polyradiculoneuropathy.
    Misra UK; Kalita J; Yadav RK
    Eur Neurol; 2007; 58(2):100-5. PubMed ID: 17565223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparative study of chronic inflammatory demyelinating polyradiculoneuropathy with and without diabetes mellitus.
    Kalita J; Misra UK; Yadav RK
    Eur J Neurol; 2007 Jun; 14(6):638-43. PubMed ID: 17539941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinguishing acute-onset CIDP from fluctuating Guillain-Barre syndrome: a prospective study.
    Ruts L; Drenthen J; Jacobs BC; van Doorn PA;
    Neurology; 2010 May; 74(21):1680-6. PubMed ID: 20427754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic inflammatory demyelinating polyradiculoneuropathy in children: characterized by subacute, predominantly motor dominant polyeuropathy with a favorable response to the treatment.
    Jo HY; Park MG; Kim DS; Nam SO; Park KH
    Acta Neurol Scand; 2010 May; 121(5):342-7. PubMed ID: 20003085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pain as the presenting symptom of chronic inflammatory demyelinating polyradiculoneuropathy (CIDP).
    Boukhris S; Magy L; Khalil M; Sindou P; Vallat JM
    J Neurol Sci; 2007 Mar; 254(1-2):33-8. PubMed ID: 17286985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Segmental evaluation of the peripheral nerve using tibial nerve SEPs for the diagnosis of CIDP.
    Tsukamoto H; Sonoo M; Shimizu T
    Clin Neurophysiol; 2010 Jan; 121(1):77-84. PubMed ID: 19850515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fatigue as the main presenting symptom of chronic inflammatory demyelinating polyradiculoneuropathy: a study of 11 cases.
    Boukhris S; Magy L; Gallouedec G; Khalil M; Couratier P; Gil J; Vallat JM
    J Peripher Nerv Syst; 2005 Sep; 10(3):329-37. PubMed ID: 16221292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Electrophysiological features of POEMS syndrome and chronic inflammatory demyelinating polyneuropathy.
    Guo X; Qin X; Zhang Y; Huang C; Yu G
    J Clin Neurosci; 2014 Apr; 21(4):587-90. PubMed ID: 24268501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patterns of nerve conduction abnormalities in POEMS syndrome.
    Sung JY; Kuwabara S; Ogawara K; Kanai K; Hattori T
    Muscle Nerve; 2002 Aug; 26(2):189-93. PubMed ID: 12210381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electrophysiological characteristics of polyneuropathy in POEMS syndrome: comparison with CIDP.
    Cui RT; Huang XS; Liu JX; Chen ZH; Pu CQ
    J Clin Neurophysiol; 2012 Aug; 29(4):345-8. PubMed ID: 22854769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different types of chronic inflammatory demyelinating polyneuropathy have a different clinical course and response to treatment.
    Jann S; Beretta S; Bramerio MA
    Muscle Nerve; 2005 Sep; 32(3):351-6. PubMed ID: 16003765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Demyelinating findings in typical and atypical chronic inflammatory demyelinating polyneuropathy: sensitivity and specificity.
    De Sousa EA; Chin RL; Sander HW; Latov N; Brannagan TH
    J Clin Neuromuscul Dis; 2009 Jun; 10(4):163-9. PubMed ID: 19494726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of electrodiagnostic abnormalities and criteria in a cohort of patients with chronic inflammatory demyelinating polyneuropathy.
    Magda P; Latov N; Brannagan TH; Weimer LH; Chin RL; Sander HW
    Arch Neurol; 2003 Dec; 60(12):1755-9. PubMed ID: 14676052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic inflammatory demyelinating polyradiculoneuropathy in diabetic patients.
    Haq RU; Pendlebury WW; Fries TJ; Tandan R
    Muscle Nerve; 2003 Apr; 27(4):465-70. PubMed ID: 12661048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of chronic inflammatory demyelinating polyneuropathy with high-dose intermittent intravenous methylprednisolone.
    Lopate G; Pestronk A; Al-Lozi M
    Arch Neurol; 2005 Feb; 62(2):249-54. PubMed ID: 15710853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Differences in the electrophysiological patterns in the distinct variations of the presentation of chronic inflammatory demyelinating polyneuropathy].
    Hernández-Hernández BA
    Rev Neurol; 2008 May 16-31; 46(10):589-92. PubMed ID: 18465697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proximal nerve conduction studies in chronic inflammatory demyelinating polyneuropathy.
    Rajabally YA; Jacob S
    Clin Neurophysiol; 2006 Sep; 117(9):2079-84. PubMed ID: 16859987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blink R1 latency utility in diagnosis and treatment assessment of polyradiculoneuropathy-organomegaly-endocrinopathy-monoclonal protein-skin changes and chronic inflammatory demyelinating polyradiculoneuropathy.
    Wang W; Litchy WJ; Mauermann ML; Dyck PJB; Dispenzieri A; Mandrekar J; Dyck PJ; Klein CJ
    Muscle Nerve; 2018 Jan; 57(1):E8-E13. PubMed ID: 28646568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sensitivity and specificity of electrodiagnostic criteria for CIDP using ROC curves: comparison to patients with diabetic and MGUS associated neuropathies.
    Wilson J; Chawla J; Fisher M
    J Neurol Sci; 2005 Apr; 231(1-2):19-28. PubMed ID: 15792816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.